首页> 外文期刊>International Journal of Molecular Sciences >Galectins as Molecular Targets for Therapeutic Intervention
【24h】

Galectins as Molecular Targets for Therapeutic Intervention

机译:半乳凝素作为治疗性干预的分子靶标

获取原文
           

摘要

Galectins are a family of small, highly conserved, molecular effectors that mediate various biological processes, including chemotaxis and angiogenesis, and that function by interacting with various cell surface glycoconjugates, usually targeting β-galactoside epitopes. Because of their significant involvement in various biological functions and pathologies, galectins have become a focus of therapeutic discovery for clinical intervention against cancer, among other pathological disorders. In this review, we focus on understanding galectin structure-function relationships, their mechanisms of action on the molecular level, and targeting them for therapeutic intervention against cancer.
机译:半乳凝素是一类小的,高度保守的分子效应子,可介导各种生物过程,包括趋化性和血管生成,并通过与通常靶向β-半乳糖苷表位的各种细胞表面糖缀合物相互作用而起作用。由于半乳凝素大量参与各种生物学功能和病理学,因此已成为针对癌症以及其他病理性疾病的临床干预的治疗发现重点。在这篇综述中,我们着重于了解半乳糖凝集素的结构-功能关系,它们在分子水平上的作用机制,并针对它们进行针对癌症的治疗性干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号